{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T14:18:33Z","timestamp":1783520313206,"version":"3.55.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T00:00:00Z","timestamp":1590192000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T00:00:00Z","timestamp":1590192000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"crossref","award":["449436\/2014-4"],"award-info":[{"award-number":["449436\/2014-4"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"crossref","award":["421143\/2018-5"],"award-info":[{"award-number":["421143\/2018-5"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"crossref","award":["158126\/2018-1"],"award-info":[{"award-number":["158126\/2018-1"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s00210-020-01910-5","type":"journal-article","created":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T05:02:46Z","timestamp":1590210166000},"page":"1931-1939","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["The involvement of GABAergic system in the antidepressant-like effect of agmatine"],"prefix":"10.1007","volume":"393","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6328-431X","authenticated-orcid":false,"given":"Vivian Binder","family":"Neis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel Foga\u00e7a","family":"Rosado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gislaine","family":"Olescowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgana","family":"Moretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscila Batista","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Platt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana L\u00facia S.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,23]]},"reference":[{"key":"1910_CR1","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1177\/0269881114544776","volume":"29","author":"CG Abdallah","year":"2015","unstructured":"Abdallah CG, Salas R, Jackowski A, Baldwin P, Sato JR, Mathew SJ (2015) Hippocampal volume and the rapid antidepressant effect of ketamine. J Psychopharmacol 29:591\u2013595","journal-title":"J Psychopharmacol"},{"key":"1910_CR2","doi-asserted-by":"publisher","first-page":"858","DOI":"10.4088\/JCP.17f11802","volume":"78","author":"C Andrade","year":"2017","unstructured":"Andrade C (2017) Ketamine for depression, 5: potential pharmacokinetic and pharmacodynamic drug interactions. J Clin Psychiatry 78:858\u2013861","journal-title":"J Clin Psychiatry"},{"key":"1910_CR3","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1159\/000118893","volume":"26","author":"B Arranz","year":"1992","unstructured":"Arranz B, Cowburn R, Eriksson A, Vestling M, Marcusson J (1992) Gamma-aminobutyric acid-B (GABAB) binding sites in postmortem suicide brains. Neuropsychobiology 26:33\u201336","journal-title":"Neuropsychobiology"},{"key":"1910_CR4","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nature10130","volume":"475","author":"AE Autry","year":"2011","unstructured":"Autry AE, Adachi M, Nosyreva E, Na ES, Los MF, Cheng PF, Kavalali ET, Monteggia LM (2011) NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature 475:91\u201395","journal-title":"Nature"},{"key":"1910_CR5","first-page":"30","volume":"1","author":"M Banasr","year":"2017","unstructured":"Banasr M, Lepack A, Fee C et al (2017) Characterization of GABAergic marker expression in the chronic unpredictable stress model of depression. Chronic Stress (Thousand Oaks) 1:30","journal-title":"Chronic Stress (Thousand Oaks)"},{"key":"1910_CR6","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jad.2018.04.016","volume":"235","author":"IO Bergfeld","year":"2018","unstructured":"Bergfeld IO, Mantione M, Figee M, Schuurman PR, Lok A, Denys D (2018) Treatment-resistant depression and suicidality. J Affect Disord 235:362\u2013367","journal-title":"J Affect Disord"},{"key":"1910_CR7","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","volume":"47","author":"RM Berman","year":"2000","unstructured":"Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, Krystal JH (2000) Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 47:351\u2013354","journal-title":"Biol Psychiatry"},{"key":"1910_CR8","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.bbr.2012.06.021","volume":"234","author":"LE Bettio","year":"2012","unstructured":"Bettio LE, Cunha MP, Budni J et al (2012) Guanosine produces an antidepressant-like effect through the modulation of NMDA receptors, nitric oxide-cGMP and PI3K\/mTOR pathways. Behav Brain Res 234:137\u2013148","journal-title":"Behav Brain Res"},{"key":"1910_CR9","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1017\/S1461145707007924","volume":"11","author":"Z Bhagwagar","year":"2008","unstructured":"Bhagwagar Z, Wylezinska M, Jezzard P, Evans J, Boorman E, M Matthews P, J Cowen P (2008) Low GABA concentrations in occipital cortex and anterior cingulate cortex in medication-free, recovered depressed patients. Int J Neuropsychopharmacol 11:255\u2013260","journal-title":"Int J Neuropsychopharmacol"},{"key":"1910_CR10","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/0163-7258(90)90077-F","volume":"48","author":"G Biggio","year":"1990","unstructured":"Biggio G, Concas A, Corda MG, Giorgi O, Sanna E, Serra M (1990) GABAergic and dopaminergic transmission in the rat cerebral cortex: effect of stress, anxiolytic and anxiogenic drugs. Pharmacol Ther 48:121\u2013142","journal-title":"Pharmacol Ther"},{"key":"1910_CR11","first-page":"252","volume":"29","author":"P Celada","year":"2004","unstructured":"Celada P, Puig M, Amargos-Bosch M et al (2004) The therapeutic role of 5-HT1A and 5-HT2A receptors in depression. J Psychiatry Neurosci 29:252\u2013265","journal-title":"J Psychiatry Neurosci"},{"key":"1910_CR12","doi-asserted-by":"crossref","unstructured":"Choudary PV, Molnar M, Evans SJ et al (2005) Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proc Natl Acad Sci USA 102:15653\u201315658","DOI":"10.1073\/pnas.0507901102"},{"key":"1910_CR13","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1177\/2045125317737264","volume":"8","author":"SS Clevenger","year":"2018","unstructured":"Clevenger SS, Malhotra D, Dang J, Vanle B, IsHak WW (2018) The role of selective serotonin reuptake inhibitors in preventing relapse of major depressive disorder. Ther Adv Psychopharmacol 8:49\u201358","journal-title":"Ther Adv Psychopharmacol"},{"key":"1910_CR14","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/0165-1781(88)90066-2","volume":"26","author":"JA Cross","year":"1988","unstructured":"Cross JA, Cheetham SC, Crompton MR, Katona CLE, Horton RW (1988) Brain GABAB binding sites in depressed suicide victims. Psychiatry Res 26:119\u2013129","journal-title":"Psychiatry Res"},{"key":"1910_CR15","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s00726-014-1910-0","volume":"47","author":"MP Cunha","year":"2015","unstructured":"Cunha MP, Pazini FL, Ludka FK, Rosa JM, Oliveira \u00c1, Budni J, Ramos-Hryb AB, Lieberknecht V, Bettio LEB, Mart\u00edn-de-Saavedra MD, L\u00f3pez MG, Tasca CI, Rodrigues ALS (2015) The modulation of NMDA receptors and L-arginine\/nitric oxide pathway is implicated in the anti-immobility effect of creatine in the tail suspension test. Amino Acids 47:795\u2013811","journal-title":"Amino Acids"},{"key":"1910_CR16","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ejphar.2014.02.045","volume":"732","author":"MP Dixit","year":"2014","unstructured":"Dixit MP, Thakre PP, Pannase AS, Aglawe MM, Taksande BG, Kotagale NR (2014) Imidazoline binding sites mediates anticompulsive-like effect of agmatine in marble-burying behavior in mice. Eur J Pharmacol 732:26\u201331","journal-title":"Eur J Pharmacol"},{"key":"1910_CR17","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.euroneuro.2005.08.005","volume":"6","author":"D Farzin","year":"2006","unstructured":"Farzin D, Mansouri N (2006) Antidepressant-like effect of harmane and other beta-carbolines in the mouse forced swim test. Eur Neuropsychopharmacol 6:324\u2013328","journal-title":"Eur Neuropsychopharmacol"},{"key":"1910_CR18","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.pnpbp.2013.12.012","volume":"50","author":"AE Freitas","year":"2014","unstructured":"Freitas AE, Bettio LE, Neis VB et al (2014) Agmatine abolishes restraint stress-induced depressive-like behavior and hippocampal antioxidant imbalance in mice. Prog Neuro-Psychopharmacol Biol Psychiatry 50:143\u2013150","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"1910_CR19","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1111\/bph.13924","volume":"174","author":"Y Gao","year":"2017","unstructured":"Gao Y, Zhou JJ, Zhu Y, Wang L, Kosten TA, Zhang X, Li DP (2017) Neuroadaptations of presynaptic and postsynaptic GABAB receptor function in the paraventricular nucleus in response to chronic unpredictable stress. Br J Pharmacol 174:2929\u20132940","journal-title":"Br J Pharmacol"},{"key":"1910_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pbb.2016.07.004","volume":"149","author":"NB Gawali","year":"2016","unstructured":"Gawali NB, Bulani VD, Chowdhury AA, Deshpande PS, Nagmoti DM, Juvekar AR (2016) Agmatine ameliorates lipopolysaccharide induced depressive-like behaviour in mice by targeting the underlying inflammatory and oxido-nitrosative mediators. Pharmacol Biochem Behav 149:1\u20138","journal-title":"Pharmacol Biochem Behav"},{"key":"1910_CR21","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.brainres.2017.03.004","volume":"1663","author":"NB Gawali","year":"2017","unstructured":"Gawali NB, Bulani VD, Gursahani MS, Deshpande PS, Kothavade PS, Juvekar AR (2017) Agmatine attenuates chronic unpredictable mild stress-induced anxiety, depression-like behaviours and cognitive impairment by modulating nitrergic signalling pathway. Brain Res 1663:66\u201377","journal-title":"Brain Res"},{"key":"1910_CR22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0376-8716(99)00148-9","volume":"60","author":"RA Glennon","year":"2000","unstructured":"Glennon RA, Dukat M, Grella B, Hong SS, Costantino L, Teitler M, Smith C, Egan C, Davis K, Mattson MV (2000) Binding of beta-carbolines and related agents at serotonin (5-HT(2) and 5-HT(1A)), dopamine (D(2)) and benzodiazepine receptors. Drug Alcohol Depend 60:121\u2013132","journal-title":"Drug Alcohol Depend"},{"key":"1910_CR23","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1080\/14656566.2018.1472767","volume":"19","author":"AF Gomez","year":"2018","unstructured":"Gomez AF, Barthel AL, Hofmann SG (2018) Comparing the efficacy of benzodiazepines and serotonergic anti-depressants for adults with generalized anxiety disorder: a meta-analytic review. Expert Opin Pharmacother 19:883\u2013894","journal-title":"Expert Opin Pharmacother"},{"key":"1910_CR24","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/j.1476-5381.1987.tb11331.x","volume":"92","author":"JA Gray","year":"1987","unstructured":"Gray JA, Green AR (1987) Increased GABAB receptor function in mouse frontal cortex after repeated administration of antidepressant drugs or electroconvulsive shocks. Br J Pharmacol 92:357\u2013362","journal-title":"Br J Pharmacol"},{"key":"1910_CR25","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1017\/S0033291712002395","volume":"43","author":"F Hardeveld","year":"2013","unstructured":"Hardeveld F, Spijker J, De Graaf R et al (2013) Recurrence of major depressive disorder and its predictors in the general population: results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Psychol Med 43:39\u201348","journal-title":"Psychol Med"},{"key":"1910_CR26","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/hup.960","volume":"23","author":"A Heinzel","year":"2008","unstructured":"Heinzel A, Steinke R, Poeppel TD, Grosser O, Bogerts B, Otto H, Northoff G (2008) S-ketamine and GABA-A-receptor interaction in humans: an exploratory study with I-123-iomazenil SPECT. Hum Psychopharmacol 23:549\u2013554","journal-title":"Hum Psychopharmacol"},{"key":"1910_CR27","first-page":"249","volume":"84","author":"DR Hill","year":"1985","unstructured":"Hill DR (1985) GABAB receptor modulation of adenylate cyclase activity in rat brain slices. Br J Pharmacol 84:249\u2013257","journal-title":"Br J Pharmacol"},{"key":"1910_CR28","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.neuropharm.2011.08.018","volume":"62","author":"MP Kaster","year":"2012","unstructured":"Kaster MP, Gadotti VM, Calixto JB, Santos ARS, Rodrigues ALS (2012) Depressive-like behavior induced by tumor necrosis factor-alpha in mice. Neuropharmacology 62:419\u2013426","journal-title":"Neuropharmacology"},{"key":"1910_CR29","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1111\/j.1471-4159.1983.tb08078.x","volume":"40","author":"J Korf","year":"1983","unstructured":"Korf J, Venema K (1983) Desmethylimipramine enhances the release of endogenous GABA and other neurotransmitter amino acids from the rat thalamus. J Neurochem 40:946\u2013950","journal-title":"J Neurochem"},{"key":"1910_CR30","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1001\/archpsyc.62.9.985","volume":"62","author":"JH Krystal","year":"2005","unstructured":"Krystal JH, Perry EB Jr, Gueorguieva R et al (2005) Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function. Arch Gen Psychiatry 62:985\u2013994","journal-title":"Arch Gen Psychiatry"},{"key":"1910_CR31","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.neubiorev.2005.03.010","volume":"29","author":"C Song","year":"2005","unstructured":"Song C, Leonard BE (2005) The olfactory bulbectomised rat as a model of depression. Neurosci Biobehav Rev 29:627\u2013647","journal-title":"Neurosci Biobehav Rev"},{"key":"1910_CR32","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1126\/science.1190287","volume":"329","author":"NX Li","year":"2010","unstructured":"Li NX, Lee B, Liu RJ, Banasr M, Dwyer JM, Iwata M, Li XY, Aghajanian G, Duman RS (2010) mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 329:959\u2013964","journal-title":"Science"},{"key":"1910_CR33","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.biopsych.2010.12.015","volume":"69","author":"N Li","year":"2011","unstructured":"Li N, Liu RJ, Dwyer JM, Banasr M, Lee B, Son H, Li XY, Aghajanian G, Duman RS (2011) Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure. Biol Psychiatry 69:754\u2013761","journal-title":"Biol Psychiatry"},{"key":"1910_CR34","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/bs.apha.2014.11.003","volume":"73","author":"B Luscher","year":"2015","unstructured":"Luscher B, Fuchs T (2015) GABAergic control of depression-related brain states. Adv Pharmacol 73:97\u2013144","journal-title":"Adv Pharmacol"},{"key":"1910_CR35","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/mp.2010.120","volume":"16","author":"B Luscher","year":"2011","unstructured":"Luscher B, Shen Q, Sahir N (2011) The GABAergic deficit hypothesis of major depressive disorder. Mol Psychiatry 16:383\u2013406","journal-title":"Mol Psychiatry"},{"key":"1910_CR36","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1159\/000118485","volume":"20","author":"G Magni","year":"1989","unstructured":"Magni G, Garreau M, Orofiamma B et al (1989) Fengabine, a new GABAmimetic agent in the treatment of depressive disorders: an overview of six double-blind studies versus tricyclics. Neuropsychobiology 20:126\u2013131","journal-title":"Neuropsychobiology"},{"key":"1910_CR37","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1176\/appi.ajp.2008.08071102","volume":"166","author":"SJ Mathew","year":"2009","unstructured":"Mathew SJ, Charney DS (2009) Publication bias and the efficacy of antidepressants. Am J Psychiatry 166:140\u2013145","journal-title":"Am J Psychiatry"},{"key":"1910_CR38","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.brainres.2005.11.015","volume":"1068","author":"KE McCarson","year":"2006","unstructured":"McCarson KE, Duric V, Reisman SA et al (2006) GABA(B) receptor function and subunit expression in the rat spinal cord as indicators of stress and the antinociceptive response to antidepressants. Brain Res 1068:109\u2013117","journal-title":"Brain Res"},{"key":"1910_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/tp.2016.116","volume":"6","author":"EM Meylan","year":"2016","unstructured":"Meylan EM, Breuillaud L, Seredenina T et al (2016) Involvement of the agmatinergic system in the depressive-like phenotype of the Crtc1 knockout mouse model of depression. Transl Psychiatry 6:1\u201311","journal-title":"Transl Psychiatry"},{"key":"1910_CR40","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.neuropharm.2011.08.040","volume":"62","author":"H Mohler","year":"2012","unstructured":"Mohler H (2012) The GABA system in anxiety and depression and its therapeutic potential. Neuropharmacology 62:42\u201353","journal-title":"Neuropharmacology"},{"key":"1910_CR41","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s12640-015-9540-1","volume":"28","author":"M Moretti","year":"2015","unstructured":"Moretti M, Neis VB, Matheus FC, Cunha MP, Rosa PB, Ribeiro CM, Rodrigues ALS, Prediger RD (2015) Effects of agmatine on depressive-like behavior induced by intracerebroventricular administration of 1-methyl-4-phenylpyridinium (MPP(+)). Neurotox Res 28:222\u2013231","journal-title":"Neurotox Res"},{"key":"1910_CR42","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1097\/00004647-199611000-00015","volume":"16","author":"JK Muir","year":"1996","unstructured":"Muir JK, Lobner D, Monyer H, Choi DW (1996) GABAA receptor activation attenuates excitotoxicity but exacerbates oxygen-glucose deprivation-induced neuronal injury in vitro. J Cereb Blood Flow Metab 16:1211\u20131218","journal-title":"J Cereb Blood Flow Metab"},{"key":"1910_CR43","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.bbr.2013.12.038","volume":"261","author":"VB Neis","year":"2014","unstructured":"Neis VB, Manosso LM, Moretti M, Freitas AE, Daufenbach J, Rodrigues ALS (2014) Depressive-like behavior induced by tumor necrosis factor-alpha is abolished by agmatine administration. Behav Brain Res 261:336\u2013344","journal-title":"Behav Brain Res"},{"key":"1910_CR44","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.pbb.2016.10.004","volume":"150-151","author":"VB Neis","year":"2016","unstructured":"Neis VB, Bettio LEB, Moretti M, Rosa PB, Ribeiro CM, Freitas AE, Gon\u00e7alves FM, Leal RB, Rodrigues ALS (2016a) Acute agmatine administration, similar to ketamine, reverses depressive-like behavior induced by chronic unpredictable stress in mice. Pharmacol Biochem Behav 150-151:108\u2013114","journal-title":"Pharmacol Biochem Behav"},{"key":"1910_CR45","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.euroneuro.2016.03.009","volume":"26","author":"VB Neis","year":"2016","unstructured":"Neis VB, Moretti M, Bettio LE et al (2016b) Agmatine produces antidepressant-like effects by activating AMPA receptors and mTOR signaling. Eur Neuropsychopharmacol 26:959\u2013971","journal-title":"Eur Neuropsychopharmacol"},{"key":"1910_CR46","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.neuint.2017.05.006","volume":"108","author":"VB Neis","year":"2017","unstructured":"Neis VB, Rosa PB, Olescowicz G, Rodrigues ALS (2017) Therapeutic potential of agmatine for CNS disorders. Neurochem Int 108:318\u2013331","journal-title":"Neurochem Int"},{"key":"1910_CR47","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.pbb.2018.08.005","volume":"173","author":"VB Neis","year":"2018","unstructured":"Neis VB, Bettio LB, Moretti M, Rosa PB, Olescowicz G, Fraga DB, Gon\u00e7alves FM, Freitas AE, Heinrich IA, Lopes MW, Leal RB, Rodrigues ALS (2018) Single administration of agmatine reverses the depressive-like behavior induced by corticosterone in mice: comparison with ketamine and fluoxetine. Pharmacol Biochem Behav 173:44\u201350","journal-title":"Pharmacol Biochem Behav"},{"key":"1910_CR48","doi-asserted-by":"publisher","first-page":"15232","DOI":"10.1073\/pnas.1404090111","volume":"111","author":"OF O\u2019Leary","year":"2014","unstructured":"O\u2019Leary OF, Felice D, Galimberti S et al (2014) GABAB(1) receptor subunit isoforms differentially regulate stress resilience. Proc Natl Acad Sci U S A 111:15232\u201315237","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1910_CR49","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.euroneuro.2011.09.001","volume":"22","author":"DH Oh","year":"2012","unstructured":"Oh DH, Son H, Hwang S, Kim SH (2012) Neuropathological abnormalities of astrocytes, GABAergic neurons, and pyramidal neurons in the dorsolateral prefrontal cortices of patients with major depressive disorder. Eur Neuropsychopharmacol 22:330\u2013338","journal-title":"Eur Neuropsychopharmacol"},{"key":"1910_CR50","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1097\/NMD.0000000000000348","volume":"203","author":"GB Parker","year":"2015","unstructured":"Parker GB, Graham RK (2015) Determinants of treatment-resistant depression: the salience of benzodiazepines. J Nerv Ment Dis 203:659\u2013663","journal-title":"J Nerv Ment Dis"},{"key":"1910_CR51","unstructured":"Patel MRBR, Kardile DP, Naik RA (2011) Agmatine inhibit the tolerance to the anxiolytic effect of diazepam in rats. Int J Pharm Appl Sci:44\u201351"},{"key":"1910_CR52","volume-title":"The mouse brain in stereotaxic coordinates","author":"G Paxinos","year":"2004","unstructured":"Paxinos G, Franklin KBJ (2004) The mouse brain in stereotaxic coordinates. Elsevier Academic Press, Amsterdam"},{"key":"1910_CR53","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/sj.mp.4000569","volume":"4","author":"F Petty","year":"1999","unstructured":"Petty F, Fulton M, Kramer GL, Kram M, Davis LL, Rush AJ (1999) Evidence for the segregation of a major gene for human plasma GABA levels. Mol Psychiatry 4:587\u2013589","journal-title":"Mol Psychiatry"},{"key":"1910_CR54","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1159\/000318293","volume":"79","author":"HE Pigott","year":"2010","unstructured":"Pigott HE, Leventhal AM, Alter GS, Boren JJ (2010) Efficacy and effectiveness of antidepressants: current status of research. Psychother Psychosom 79:267\u2013279","journal-title":"Psychother Psychosom"},{"key":"1910_CR55","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.drudis.2013.05.017","volume":"18","author":"JE Piletz","year":"2013","unstructured":"Piletz JE, Aricioglu F, Cheng JT, Fairbanks CA, Gilad VH, Haenisch B, Halaris A, Hong S, Lee JE, Li J, Liu P, Molderings GJ, Rodrigues ALS, Satriano J, Seong GJ, Wilcox G, Wu N, Gilad GM (2013) Agmatine: clinical applications after 100 years in translation. Drug Discov Today 18:880\u2013893","journal-title":"Drug Discov Today"},{"key":"1910_CR56","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/00004850-199100640-00001","volume":"6","author":"RM Post","year":"1991","unstructured":"Post RM, Ketter TA, Joffe RT, Kramlinger KL (1991) Lack of beneficial effects of l-baclofen in affective disorder. Int Clin Psychopharmacol 6:197\u2013207","journal-title":"Int Clin Psychopharmacol"},{"key":"1910_CR57","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.biopsych.2008.10.025","volume":"65","author":"RB Price","year":"2009","unstructured":"Price RB, Shungu DC, Mao X, Nestadt P, Kelly C, Collins KA, Murrough JW, Charney DS, Mathew SJ (2009) Amino acid neurotransmitters assessed by proton magnetic resonance spectroscopy: relationship to treatment resistance in major depressive disorder. Biol Psychiatry 65:792\u2013800","journal-title":"Biol Psychiatry"},{"key":"1910_CR58","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.biopsych.2016.02.009","volume":"80","author":"Z Ren","year":"2016","unstructured":"Ren Z, Pribiag H, Jefferson SJ, Shorey M, Fuchs T, Stellwagen D, Luscher B (2016) Bidirectional homeostatic regulation of a depression-related brain state by gamma-aminobutyric acidergic deficits and ketamine treatment. Biol Psychiatry 80:457\u2013468","journal-title":"Biol Psychiatry"},{"key":"1910_CR59","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/j.1600-0773.1996.tb00259.x","volume":"79","author":"AL Rodrigues","year":"1996","unstructured":"Rodrigues AL, Rocha JB, Mello CF, Souza DO (1996) Effect of perinatal lead exposure on rat behaviour in open-field and two-way avoidance tasks. Pharmacol Toxicol 79:150\u2013156","journal-title":"Pharmacol Toxicol"},{"key":"1910_CR60","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.pharep.2016.05.010","volume":"68","author":"PB Rosa","year":"2016","unstructured":"Rosa PB, Neis VB, Ribeiro CM, Moretti M, Rodrigues ALS (2016) Antidepressant-like effects of ascorbic acid and ketamine involve modulation of GABAA and GABAB receptors. Pharmacol Rep 68:996\u20131001","journal-title":"Pharmacol Rep"},{"key":"1910_CR61","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1124\/jpet.115.230391","volume":"356","author":"K Sapkota","year":"2016","unstructured":"Sapkota K, Mao Z, Synowicki P, Lieber D, Liu M, Ikezu T, Gautam V, Monaghan DT (2016) GluN2D N-methyl-d-aspartate receptor subunit contribution to the stimulation of brain activity and gamma oscillations by ketamine: implications for schizophrenia. J Pharmacol Exp Ther 356:702\u2013711","journal-title":"J Pharmacol Exp Ther"},{"key":"1910_CR62","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.tips.2018.03.006","volume":"39","author":"E Sigel","year":"2018","unstructured":"Sigel E, Ernst M (2018) The benzodiazepine binding sites of GABAA receptors. Trends Pharmacol Sci 39:659\u2013671","journal-title":"Trends Pharmacol Sci"},{"key":"1910_CR63","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1177\/070674371305800703","volume":"58","author":"J Spijker","year":"2013","unstructured":"Spijker J, van Straten A, Bockting CL et al (2013) Psychotherapy, antidepressants, and their combination for chronic major depressive disorder: a systematic review. Can J Psychiatr 58:386\u2013392","journal-title":"Can J Psychiatr"},{"key":"1910_CR64","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/BF00428203","volume":"85","author":"L Steru","year":"1985","unstructured":"Steru L, Chermat R, Thierry B, Simon P (1985) The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 85:367\u2013370","journal-title":"Psychopharmacology"},{"key":"1910_CR65","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ejphar.2010.03.058","volume":"637","author":"BG Taksande","year":"2010","unstructured":"Taksande BG, Kotagale NR, Patel MR, Shelkar GP, Ugale RR, Chopde CT (2010) Agmatine, an endogenous imidazoline receptor ligand modulates ethanol anxiolysis and withdrawal anxiety in rats. Eur J Pharmacol 637:89\u2013101","journal-title":"Eur J Pharmacol"},{"key":"1910_CR66","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.biopha.2017.07.004","volume":"93","author":"BG Taksande","year":"2017","unstructured":"Taksande BG, Sharma O, Aglawe MM, Kale MB, Gawande DY, Umekar MJ, Kotagale NR (2017) Acute orexigenic effect of agmatine involves interaction between central alpha2-adrenergic and GABAergic receptors. Biomed Pharmacother 93:939\u2013947","journal-title":"Biomed Pharmacother"},{"key":"1910_CR67","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.neuint.2018.05.006","volume":"118","author":"MK Tavares","year":"2018","unstructured":"Tavares MK, Dos Reis S, Platt N et al (2018) Agmatine potentiates neuroprotective effects of subthreshold concentrations of ketamine via mTOR\/S6 kinase signaling pathway. Neurochem Int 118:275\u2013285","journal-title":"Neurochem Int"},{"key":"1910_CR68","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.jad.2015.11.018","volume":"190","author":"MM Vasavada","year":"2016","unstructured":"Vasavada MM, Leaver AM, Espinoza RT, Joshi SH, Njau SN, Woods RP, Narr KL (2016) Structural connectivity and response to ketamine therapy in major depression: a preliminary study. J Affect Disord 190:836\u2013841","journal-title":"J Affect Disord"},{"key":"1910_CR69","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1113\/jphysiol.2014.281378","volume":"593","author":"HY Wang","year":"2015","unstructured":"Wang HY, Kuo ZC, Fu YS, Chen RF, Min MY, Yang HW (2015) GABAB receptor-mediated tonic inhibition regulates the spontaneous firing of locus coeruleus neurons in developing rats and in citalopram-treated rats. J Physiol 593:161\u2013180","journal-title":"J Physiol"},{"key":"1910_CR70","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1097\/ALN.0000000000001483","volume":"126","author":"DS Wang","year":"2017","unstructured":"Wang DS, Penna A, Orser BA (2017) Ketamine increases the function of gamma-aminobutyric acid type A receptors in hippocampal and cortical neurons. Anesthesiology 126:666\u2013677","journal-title":"Anesthesiology"},{"key":"1910_CR71","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1073\/pnas.1718883115","volume":"115","author":"AJ Widman","year":"2018","unstructured":"Widman AJ, McMahon LL (2018) Disinhibition of CA1 pyramidal cells by low-dose ketamine and other antagonists with rapid antidepressant efficacy. Proc Natl Acad Sci U S A 115:3007\u20133016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1910_CR72","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.neuropharm.2013.05.037","volume":"73","author":"ER Workman","year":"2013","unstructured":"Workman ER, Niere F, Raab-Graham KF (2013) mTORC1-dependent protein synthesis underlying rapid antidepressant effect requires GABABR signaling. Neuropharmacology 73:192\u2013203","journal-title":"Neuropharmacology"},{"key":"1910_CR73","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.neulet.2015.10.049","volume":"610","author":"T Yamamoto","year":"2016","unstructured":"Yamamoto T, Nakayama T, Yamaguchi J, Matsuzawa M, Mishina M, Ikeda K, Yamamoto H (2016) Role of the NMDA receptor GluN2D subunit in the expression of ketamine-induced behavioral sensitization and region-specific activation of neuronal nitric oxide synthase. Neurosci Lett 610:48\u201353","journal-title":"Neurosci Lett"},{"key":"1910_CR74","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","volume":"63","author":"CA Zarate","year":"2006","unstructured":"Zarate CA, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, Charney DS, Manji HK (2006) A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 63:856\u2013864","journal-title":"Arch Gen Psychiatry"},{"key":"1910_CR75","doi-asserted-by":"crossref","unstructured":"Zhang T, Du Y, Liu X et al (2019) Study on antidepressant-like effect of protoilludane sesquiterpenoid aromatic esters from Armillaria Mellea. Nat Prod Res:1\u20134","DOI":"10.1080\/14786419.2019.1614577"},{"key":"1910_CR76","doi-asserted-by":"crossref","unstructured":"Zheng W, Xiao-Hong L, Xiao-Min Z et al (2019) Adjunctive ketamine and electroconvulsive therapy for major depressive disorder: A meta-analysis of randomized controlled trials. J Affec Dis 250:123\u2013131","DOI":"10.1016\/j.jad.2019.02.044"},{"key":"1910_CR77","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/00001756-200203250-00005","volume":"13","author":"ADE Zomkowski","year":"2002","unstructured":"Zomkowski ADE, Hammes L, Lin J, Calixto JB, Santos ARS, Rodrigues ALS (2002) Agmatine produces antidepressant-like effects in two models of depression in mice. Neuroreport 13:387\u2013391","journal-title":"Neuroreport"},{"key":"1910_CR78","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.brainres.2004.07.041","volume":"1023","author":"ADE Zomkowski","year":"2004","unstructured":"Zomkowski ADE, Rosa AO, Lin J et al (2004) Evidence for serotonin receptor subtypes involvement in agmatine antidepressant like-effect in the mouse forced swimming test. Brain Res 1023:253\u2013263","journal-title":"Brain Res"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-020-01910-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-020-01910-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-020-01910-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,22]],"date-time":"2021-05-22T23:08:33Z","timestamp":1621724913000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-020-01910-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,23]]},"references-count":78,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["1910"],"URL":"https:\/\/doi.org\/10.1007\/s00210-020-01910-5","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,23]]},"assertion":[{"value":"26 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Animals were used according to the National Institutes of Health Guide for the Care and Use of Laboratory Animals, and the protocol and experiments were approved by the Ethical Committee of Animal Research of Federal University of Santa Catarina.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}